Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

S Jon Saxe


  • at Vistagen Therapeutics Inc. (VTGN), 2020-08-24
  • Director at Durect Corp (DRRX), 2020-06-19
  • Director at Sciclone Pharmaceuticals Inc (SCLN), 2017-10-16
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VTGN $0.69 30,000 50,000 2020-08-21 Filing
DRRX $0.56 2,900 Director 150,000 2019-06-10 Filing
DRRX $0.56 74 Director 147,100 2019-06-10 Filing
DRRX $0.56 626 Director 147,026 2019-06-10 Filing
DRRX $0.56 3,449 Director 146,400 2019-06-10 Filing